Research Square (Research Square),
Journal Year:
2023,
Volume and Issue:
unknown
Published: March 31, 2023
Abstract
Background
COVID-19
could
develop
severe
respiratory
symptoms
in
certain
infected
patients,
especially
the
patients
with
immune
disorders.
Gut
microbiome
and
plasma
metabolome
act
important
immunological
modulators
human
body
contribute
to
responses
impacting
progression
of
COVID-19.
Methods
Based
on
two-sample
Mendelian
randomization
framework,
causal
effects
131
microbiota
genus
or
species
level
452
metabolites
are
estimated.
Single
nucleotide
polymorphisms
(SNPs)
strongly
associated
abundance
intestinal
bacteria
gut
concentration
have
been
utilized
as
instrument
variables
infer
whether
they
factors
In
addition,
mediation
analysis
is
conducted
find
potential
link
between
metabolite
which
identified
by
polygenic
analysis,
while
colocalization
has
performed
validate
relationships
cis
-Mendelian
analysis.
Results
support
13
53
metabolites,
significantly
association
Mediation
11
mediated
relations,
such
myo-inositol,
2-stearoylglycerophosphocholine
alpha-glutamyltyrosine,
appeared
mediate
Howardella
Ruminiclostridium
6
respectively,
Butyrivibrio
Ruminococcus
gnavus
myo-inositol
N-acetylalanine
respectively.
torques
was
colocalized
(PP.H4
=
0.77)
colon
expression
permeability
related
protein
RASIP1
0.95).
Conclusions
Our
study
results
highlight
for
COVID-19,
promise
be
served
clinical
biomarkers
risk
stratification
prognostication,
novel
basis
unravel
pathophysiological
mechanisms
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(22), P. 12199 - 12199
Published: Nov. 13, 2024
The
COVID-19
outbreak
caused
saturations
of
hospitals,
highlighting
the
importance
early
patient
triage
to
optimize
resource
prioritization.
Herein,
our
objective
was
test
if
high
definition
metabolomics,
combined
with
ML,
can
improve
prognostication
and
performance
over
standard
clinical
parameters
using
COVID
infection
as
an
example.
Using
resolution
mass
spectrometry,
we
obtained
metabolomics
profiles
patients
them
design
machine
learning
(ML)
algorithms
predicting
severity
(herein
determined
need
for
mechanical
ventilation
during
care).
A
total
64
PCR-positive
at
Poitiers
CHU
were
recruited.
Clinical
investigations
conducted
8
days
after
onset
symptoms.
We
show
that
could
predict
good
(AUC
ROC
curve:
0.85),
SpO2,
first
respiratory
rate,
Horowitz
quotient
age
most
important
variables.
However,
prediction
substantially
improved
by
use
=
0.92).
Our
small-scale
study
demonstrates
diagnosis
prognosis
algorithms,
thus
be
a
key
player
in
future
discovery
new
biological
signals.
This
technique
is
easily
deployable
clinic,
learning,
it
help
mathematical
models
needed
advance
towards
personalized
medicine.
COVID,
Journal Year:
2023,
Volume and Issue:
3(4), P. 567 - 591
Published: April 13, 2023
The
nasal
microenvironment
plays
a
crucial
role
in
the
transmission,
modulation,
and
clinical
progression
of
COVID-19;
however,
immune
responses
at
site
viral
entry
remain
poorly
understood.
We
deciphered
link
between
nasopharyngeal
(NP)
inflammatory
response
that
triggers
cytokine/chemokine
storms
route
COVID-19-positive
patients.
used
RT-PCR,
multiplex
ELISA,
flow
cytometry,
LC-MS/MS
to
decipher
perturbations
associated
with
severe
COVID-19.
In
addition,
we
performed
vitro
assays
using
cultured
human
monocytes-derived
macrophages
trained
both
presence
absence
SARS-CoV-2
trimeric
spike
protein(s)
co-cultured
without
autologous
peripheral
blood
mononuclear
cells
(hPBMCs)/total
T-cells/CD8
T-cells.
were
examined
by
cytometry
assays.
Our
findings
confirm
orchestrate
NP
highlight
increased
CD8+T-cells
along
Tregs,
Th1,
Th17.1
T-helper
cells.
observed
correlation
macrophages,
profoundly
M2c,
differentially
promote
surfactome
on
CD8
T-cells,
including
ITGAM,
LGALS3,
CD38,
TKT,
LRPAP1,
SSBP1.
this
study
conclude
lymphocyte
within
nasopharynx
COVID-19
patients
may
enforce
homeostasis
during
SARS-CoV-2-infection
contribute
pathology.
This
explored
therapeutic
target
proteins
could
facilitate
development
new
medications,
which
allow
for
immediate
treatment
possible
emerging
infections.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: April 4, 2024
SARS-CoV-2
burdens
healthcare
systems
worldwide,
yet
specific
drug-based
treatments
are
still
unavailable.
Understanding
the
effects
of
on
host
molecular
pathways
is
critical
for
providing
full
descriptions
and
optimizing
therapeutic
targets.
The
present
study
used
Nuclear
Magnetic
Resonance-based
metabolic
footprinting
to
characterize
secreted
cellular
metabolite
levels
(exometabolomes)
Vero
E6
cells
in
response
infection
two
candidate
drugs
(Remdesivir,
RDV,
Azithromycin,
AZI),
either
alone
or
combination.
appears
force
VE6
have
increased
glucose
concentrations
from
extra-cellular
medium
altered
energetic
metabolism.
RDV
AZI,
combination,
can
modify
glycolic-gluconeogenesis
pathway
cell,
thus
impairing
mitochondrial
oxidative
damage
caused
by
primary
phase.
treatment
be
associated
with
a
shift
toward
TCA
cycle.
Our
findings
reveal
reprogramming
produced
studied
pharmacological
that
protects
against
virus-induced
damage,
an
emphasis
glycolytic-gluconeogenetic
pathway.
These
may
help
researchers
better
understand
relevant
biological
mechanisms
involved
viral
infection,
as
well
creation
mechanistic
hypotheses
such
drugs,
thereby
opening
up
new
possibilities
therapy.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Jan. 17, 2023
Abstract
Deep
metabolomic,
proteomic
and
immunologic
phenotyping
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
patients
have
matched
a
wide
diversity
clinical
symptoms
with
potential
biomarkers
for
disease
2019
(COVID-19).
Within
here,
several
studies
described
the
role
metabolites,
lipoproteins
inflammation
markers
during
infection
in
recovered
patients.
In
fact,
after
SARS-CoV-2
viral
almost
20-30%
experience
persistent
even
12
weeks
recovery
which
has
been
defined
as
long-term
COVID-19
(LTCS).
Emerging
evidence
revealed
that
dysregulated
immune
system
persisting
could
be
one
key
drivers
LTCS.
However,
how
these
small
biomolecules
such
lipoprotein,
cytokines
chemokines
altogether
govern
pathophysiology
is
largely
underexplored.
Thus,
clear
understanding
parameters
into
an
integrated
fashion
predict
course
may
help
to
stratify
LTCS
from
or
specimen
would
elucidate
mechanistic
course.
Here,
we
report
analysis
blood
serum
plasma
by
vitro
diagnostics
research
NMR
spectroscopy
flow
cytometry-based
cytokine
quantification
total
125
individuals
(healthy
controls
(HC;
n=73),
(n=12),
(n=7)
(n=33)).
We
identified
lactate
pyruvate
were
significantly
different
either
healthy
Further
correlational
metabolites
indicated
creatine,
glutamine,
high-density
lipoprotein
(HDL)
phospholipids
distributed
differentially
amongst
individuals.
Of
note,
triglycerides
(apolipoproteins
Apo-A1
A2)
demonstrate
COVID-19-like
alterations
compared
HC.
Interestingly,
samples
distinguished
mostly
their
creatinine,
phenylalanine,
succinate,
3-hydroxybutyrate
(3-HB)
glucose
concentrations,
illustrating
imbalanced
energy
metabolism.
Most
present
at
low
levels
HC
except
IL-18
chemokine,
tended
higher
correlated
positively
amino
acids
(creatine,
histidine,
leucine,
valine),
(lactate
3-HB)
lipoproteins.
The
identification
will
better
other
diseases
ongoing
severity
Graphical
abstract
Layman
summary
&
significance
Almost
infected
virus
regardless
hospitalization
status
It
devasting
millions
worldwide
hardly
anything
known
about
why
some
people
3
months
phase.
this,
attempted
understand
whether
metabolism
contributing
factors
Total
Cory
cycle
pyruvate)
higher,
(Apo-A1
drastically
lower
controls.
Correlation
age
gender
are
(citrate,
glutamate,
3-hydroxybutyrate,
glucose)
(Apo-A1,
HDL
Apo-A1,
LDL
triglycerides)
Several
also
thus,
dysregulation
contributory
factor
symptoms.
Research Square (Research Square),
Journal Year:
2023,
Volume and Issue:
unknown
Published: March 31, 2023
Abstract
Background
COVID-19
could
develop
severe
respiratory
symptoms
in
certain
infected
patients,
especially
the
patients
with
immune
disorders.
Gut
microbiome
and
plasma
metabolome
act
important
immunological
modulators
human
body
contribute
to
responses
impacting
progression
of
COVID-19.
Methods
Based
on
two-sample
Mendelian
randomization
framework,
causal
effects
131
microbiota
genus
or
species
level
452
metabolites
are
estimated.
Single
nucleotide
polymorphisms
(SNPs)
strongly
associated
abundance
intestinal
bacteria
gut
concentration
have
been
utilized
as
instrument
variables
infer
whether
they
factors
In
addition,
mediation
analysis
is
conducted
find
potential
link
between
metabolite
which
identified
by
polygenic
analysis,
while
colocalization
has
performed
validate
relationships
cis
-Mendelian
analysis.
Results
support
13
53
metabolites,
significantly
association
Mediation
11
mediated
relations,
such
myo-inositol,
2-stearoylglycerophosphocholine
alpha-glutamyltyrosine,
appeared
mediate
Howardella
Ruminiclostridium
6
respectively,
Butyrivibrio
Ruminococcus
gnavus
myo-inositol
N-acetylalanine
respectively.
torques
was
colocalized
(PP.H4
=
0.77)
colon
expression
permeability
related
protein
RASIP1
0.95).
Conclusions
Our
study
results
highlight
for
COVID-19,
promise
be
served
clinical
biomarkers
risk
stratification
prognostication,
novel
basis
unravel
pathophysiological
mechanisms